Kate Farms Closes $75M in Series C Funding
- Kate Farms, a Santa Barbara, CA-based company that brings plant-based nutrition into healthcare, raised $75M in Series C funding
- The round was led by Novo Holdings, with participation from Kaiser Permanente Ventures, Goldman Sachs Asset Management, and Main Street Advisors
- The company intends to use the funds to accelerate innovation in its current product portfolio, develop new products and enter new channels
- KateFarms produces plant-based organic and clinically demonstrated formulas for tube and oral feeding to help nourish those with chronic illnesses and acute conditions
- The company offers medical formulas made for tolerance with easily digested organic pea protein, fiber and phytonutrients, and without common allergens, artificial sweeteners or flavors
